Enter your Email Address


Useful Links

Know What The Insiders Are Doing!
Make a Living as a Trader
Stock Trading Software

More Links




[Most Recent Quotes from www.kitco.com]

[Most Recent Quotes from www.kitco.com]





Zacks Bull and Bear of the Day Highlights: Cytori Therapeutics, Red Robin Gourmet Burgers Inc., Ford, Eaton and TRW Automotive – Press Releases

Zacks Market Commentaries (October 19th, 2009) Writes:

For Immediate Release

Chicago, IL – October 19, 2009 – Zacks Equity Research highlights Cytori Therapeutics (CYTX) as the Bull of the Day and Red Robin Gourmet Burgers Inc. (RRGB) the Bear of the Day. In addition, Zacks Equity Research provides analysis on Ford (F), Eaton (ETN) and TRW Automotive (TRW).

Full analysis of all these stocks is available at http://at.zacks.com/?id=2676

Here is a synopsis of all five stocks:

Bull of the Day:

We continue to be very positive on Cytori Therapeutics (CYTX) and believe the company's Celution System, a better mousetrap for quickly and efficiently harvesting adult stem cells, will see sales ramp significantly over the next few years.

Sales of the system have been tracking with our expectations. Ultimately, the clinical data will determine the pace at which the ramp continues. So far, the clinical data has been exciting,

...

Cytori’s Celution Starting to Ramp – Analyst Blog

Zacks Market Commentaries (May 11th, 2009) Writes:
On May 11, 2009, Cytori Therapeutics (CYTX) released financial results for the first quarter 2009. Total revenues in the first quarter were $1.92 million, and were comprised primarily of $1.3 million European and Asian Celution System sales and $0.6 million in StemSource revenues in Japan. These results were essentially in-line with our $1.99 million estimate.During the quarter, management or its partners placed a total of 19 Celution Systems and 241 Consumables into the marketplace. Of the 19 Celution Systems, 13 were sold into the market place and 6 were placed into centers active in clinical trial.Net loss for the first quarter totaled $6.1 million, or ($0.20) per share.  This was slightly wider than our $5.3 million, ($0.18) per share, estimate based on a $0.8 net charge for a change in fair value of warrants and option liability during the quarter.Enrollment in the ...

Newsletter

No recommendations, either expressed or implied, are being made to buy, sell, hold or short any of the mentioned stocks. No legal, tax or accounting advice is expressed or implied. Always contact your attorney, CPA, or tax advisor before acting on any legal or tax issues. StraightStocks.com is not responsible for the content, products, or services of any of the advertisers on this site. StraightStocks.com receives compensation from advertisers on this blog. Services and products referred to herein are trademarks, registered trademarks, servicemarks, and/or registered servicemarks of their respective trademark or servicemark owners.